The president of Medicines for Europe, Steffen Saltofte, says Medicines for Europe will focus on ensuring equitable access to medicines as a right, not a privilege, while also strengthening industry resilience, competitiveness, a harmonised regulatory framework and sustainability for the European off-patent, generics, biosimilars and value added medicines sector.
Read the words of our President and full Article below.